|

NRX-101 Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: lurasidone and d-cycloserine

Pipeline

Early 1: 1Phase 2/3: 1

Top Sponsors

  • NeuroRx, Inc.1
  • Mclean Hospital1

Indications

  • Depression2
  • Treatment Resistant Depression (TRD)1
  • Treatment-resistant Depression1
  • Major Depression1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.